Facebook Linkedin RSS Twitter Youtube
Home 2022

Hemophilia B

Rising Star: Vega Targets Rare Blood Disorders with Antibodies
GEN Edge

Rising Star: Vega Targets Rare Blood Disorders with Antibodies

Alex Philippidis -
0
First Gene Therapy Approved for Adults with Hemophilia B
Genome Editing

First Gene Therapy Approved for Adults with Hemophilia B

John Sterling -
47
Hemophilia B Gene Therapy Shows Promise in Clinical Trial
Drug Discovery

Hemophilia B Gene Therapy Shows Promise in Clinical Trial

Anjali A. Sarkar, PhD -
0
AstraZeneca -Calquence<sup>®</sup>® />
News

AstraZeneca -Calquence®

Alex Philippidis -
0
CRISPR “One Shot” Cell Therapy for Hemophilia Developed
Drug Discovery

CRISPR “One Shot” Cell Therapy for Hemophilia Developed

GEN Staff Writer -
0
Improvements to Gene Therapy Clinical Trial Design Benefit Hemophilia Patients
Insights

Improvements to Gene Therapy Clinical Trial Design Benefit Hemophilia Patients

Karen Weintraub -
0
Sangamo Genome Editing Trial, Assessing MPS II Candidate, Treats First Patient
Genome Editing

Sangamo Genome Editing Trial, Assessing MPS II Candidate, Treats First Patient

GEN Staff Writer -
0
Chiesi Ends Collaboration with uniQure on Hemophilia B Gene Therapy Candidate
Genome Editing

Chiesi Ends Collaboration with uniQure on Hemophilia B Gene Therapy Candidate

GEN Staff Writer -
0
uniQure Axing 50 to 60 Positions in Restructuring
Industry News

uniQure Axing 50 to 60 Positions in Restructuring

GEN Staff Writer -
0
Novel Gene Therapy Payment Model Proposed
Genome Editing

Novel Gene Therapy Payment Model Proposed

GEN Staff Writer -
0
123Page 1 of 3
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.